Results 61 to 70 of about 250 (83)

Collagenase Clostridium Histolyticum for the Treatment of Dupuytren Disease: A Delphi-Based Consensus Study. [PDF]

J Hand Surg Glob Online
Pess GM, Hurley D, Verheyden JR, Benhaim P.   +3 more
europepmc   +1 more source

Reimagining Ambulatory Care in Urology: Conversion of the Urology Clinic into a Procedure Center Improves Patient's Experience. [PDF]

Telemed J E Health
Hamouche F, Hakam N, Unno R, Ahn J, Yang H, Bayne D, Stoller ML, Smith S, Finlayson E, Smith J, Chi T.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections

Urology, 2020
Faysal Yafi, Farouk Elkhatib
exaly  

A survey of exposure to the use of Xiaflex for the treatment of Peyronie’s disease among United States urology residency programs

International Journal of Impotence Research, 2023
Thomas Masterson, Justin Loloi, Ranjith Ramasamy   +2 more
exaly  

(161) Xiaflex Nonresponders Show Alteration in Penile Measurements: Post-Market Analysis of Predictors for Treatment Success

Journal of Sexual Medicine, 2023
W Hellström, S Sikka, B Herzog
exaly  

(309) Risk Factors Associated with the Utilization of Xiaflex Injections for Peyronie’s Disease

Journal of Sexual Medicine, 2023
exaly  

Surgical findings in the treatment of Dupuytren’s disease after initial treatment with clostridial collagenase (Xiaflex)

Journal of Hand Surgery: European Volume, 2014
Brandon Earp
exaly